无细胞百日咳疫苗生产用菌种CMCC58003Fim2、Fim3抗原成分的血清学检测  

Serological analysis for Fim2 and Fim3 antigen components in bacterial seeds CMCC58003 used for aP Vaccine production

作　　者：罗勇[1] 赖军[1] 严东珍[1] 高慧[1] 潘海龙[1] 

机构地区：[1]成都生物制品研究所有限责任公司,成都610023

出　　处：《职业卫生与病伤》2013年第1期43-44,共2页Occupational Health and Damage

摘　　要：目的检测无细胞百日咳疫苗生产用菌种CMCC58003(简称CMCC58003)的Fim2、Fim3抗原成分。方法运用玻片凝集试验法进行检测。结果现有5个批次CMCC58003的Fim2、Fim3抗原成分的玻片凝集试验均为阳性。结论 5个批次CMCC58003的Fim2、Fim3抗原成分的血清学检测结论为合格。Objective To analyze Fim2 and Fim3 antigen components in bacterial seed CMCC58003 which is used to produce aP vaccine. Method Glass slide agglutination test is used to analysis. Result Glass slide agglutination test shows current 5 batches of CMCC58003 seeds are all Fim2 and Fim3 antigen-positive. Conclusion Fim2 and Fire3 antigen component in 5 batches of bacterial seeds CMCC58003 are qualified in Serological analysis test.

关 键 词：无细胞百日咳疫苗 CMCC58003 Fim2、Fim3抗原成分 玻片凝集试验法. 

分 类 号：R392.11[医药卫生—免疫学]